PRP treatment for hair loss shows some evidence of effectiveness, with HT surgeons using it post-op to promote growth. Microneedling is mentioned as a cheaper alternative.
A user shared their positive experience 5 months after a hairtransplant, emphasizing the importance of thorough research and using finasteride and minoxidil to control hair loss. They had 3700 grafts transplanted to the front/mid-scalp and used medications to fill in the crown.
User discusses using Verteporfin for hair regrowth after hairtransplant. Replies mention successful follicle regrowth in studies and mice, questioning if it can be replicated in humans.
Hair follicle regenerative therapy is being developed, with clinical trials planned in Japan, potentially allowing for hair cloning and eliminating the need for treatments like finasteride. If successful, the treatment could be available in Japan by 2025, but widespread access and affordability may take longer.
The user wants to undergo laser hair removal on a bad hairtransplant and maintain their natural hairline. They are seeking shampoo recommendations while using finasteride and minoxidil.
Longitudinal partial follicular unit transplantation involves extracting part of the donor follicular unit, allowing the donor area to be overharvested without noticeable hair loss. The conversation questions if this method is practiced in clinics or if it's theoretical, and whether it relates to hair cloning or multiplication.
A trans woman is using finasteride, minoxidil, microneedling, and HRT to address hair loss, with noticeable improvement in hairline shape and presence of vellus hairs. She is considering hairtransplants if these treatments don't yield desired results within a year or two.
A 27-year-old using minoxidil and dutasteride for hair loss has seen significant improvement but is considering a hairtransplant for a more defined hairline. Most responses suggest the hair looks good, advise against a transplant, and recommend patience or trying microneedling or tretinoin.
Hair regeneration and follicle cloning are considered far from being feasible, with current treatments like finasteride, minoxidil, and hairtransplants expected to remain dominant for the next 15-20 years. Some are hopeful that AI advancements might accelerate progress, but many remain skeptical about significant breakthroughs in the near future.
A human trial of verteporfin, a potential treatment for hair loss, with some users noting potential improvements in scarring and overall healing compared to control areas.
A user shared an 8-month update on their hairtransplant surgery, which used 1800 grafts for aesthetic refinement, resulting in a natural-looking hairline and improved confidence. The procedure was performed by Dr. Abhinav Kumar, and the user is pleased with the results.
The user is unsatisfied with their hairtransplant and is considering another transplant, PRP, exosomes, or stem cells. They currently use topical minoxidil, dutasteride, and tretinoin.
Akshay Kumar's hair restoration appears conservative, likely involving a small-session FUE hairtransplant or non-surgical treatments like PRP, with subtle improvements in density and frontal framing. The overall success is rated 3.5/5, with ongoing maintenance suggested for longevity.
Gene editing for hair loss is not yet viable due to technological and economic challenges. Current treatments like Minoxidil, finasteride, and hairtransplants remain the most practical options.
A 35-year-old shared a 7-day update on their hairtransplant, which involved 3,153 grafts performed by Dr. Elif at HLC Ankara, costing 10,000 euros including accommodations. The user has been on finasteride for over 12 years and opted for a partial shave FUE to address hairline recession and temple peaks.
A South Korean company, Therazyne, has developed a promising hair loss treatment using a WNT chain surrogate that binds to Frizzled 7, with human follicle testing expected soon. Current treatments like minoxidil and finasteride are not seen as cures, and while optimism exists for future solutions like PP405, approval processes are lengthy.
A 26-year-old male considering a hairtransplant is using topical finasteride and minoxidil, planning to start feminizing hormone replacement therapy (HRT) with estrogen and spironolactone. Many suggest waiting to see the effects of HRT, which may significantly regrow hair, before deciding on a transplant, and recommend adding microneedling and possibly switching to oral treatments for better results.
The conversation discusses concerns about microneedling potentially causing damage before a hairtransplant, with users sharing their experiences and techniques. Specific treatments mentioned include using a dermapen at various depths and speeds, with some users advising against self-treatment.
A user asked how much people would pay for guaranteed hair cloning, with responses ranging from $3.50 to $20,000. The conversation did not mention specific treatments like Minoxidil, finasteride, or RU58841.
A 40-year-old considering a hairtransplant after using finasteride and oral minoxidil for hair maintenance. They have maintained hair well with these treatments and seek opinions on whether a transplant would improve their appearance.
A user trying to avoid an expensive hairtransplant, and the replies suggesting they wait two years on treatment before deciding if they need a transplant or not.
A user shared their hairtransplant journey, showing progress from February 2021 to May/June 2024. They now use finasteride, minoxidil, biotin, and Nizoral shampoo, and are happy with the results.
A 39-year-old from Bangalore shared his successful hairtransplant journey, which included 3537 scalp and 1521 beard grafts, boosting his confidence. He also started medication alongside the transplant.
A 35-year-old man had a hairtransplant in 2019 but experienced further hair loss due to not using finasteride or minoxidil. Many suggest shaving his head or considering a hair system, as his donor area is depleted and further transplants may not be viable.
The conversation is about whether doctors are offering hairtransplants using verteporfin. Dr. Bargouthi in Jordan and Dr. Bloxham in New York are currently conducting trials on it.
A user shared impressive progress at 4 months post-hairtransplant with 5120 grafts by Dr. Ahmet Yildirim in Istanbul. The user expressed satisfaction with the results, which exceeded expectations.
The conversation discusses a patent filed by Shiseido for cloning Dermal Papilla (DP) cells to treat hair loss. The method involves using viral vectors to maintain the cells' growth-inducing properties, differing from Replicel's approach with Dermal Sheath Cup (DSC) cells.
The user had two FUT hairtransplants with 4,600 grafts for increased density, costing about $11,000 each, and has been using oral minoxidil and finasteride for over five years without side effects. The results are natural-looking with no visible scarring, and the user finds the procedure valuable despite the cost.
A recent discovery in hair cloning identified a previously unknown cell type essential for hair follicle growth, which could potentially make lab-grown hair viable if translated to humans. However, skepticism remains due to past delays and the challenges of replicating results in humans and making the process affordable.
Stem cell-related treatments and drugs like RCGD423 and WAY are being tested for hair growth. Clinics are conducting tests on patients who haven't had previous treatments.